ANAB - ANAPTYSBIO, INC
64.67
2.660 4.113%
Share volume: 901,628
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$62.01
2.66
0.04%
Summary score
60%
Profitability
46%
Dept financing
41%
Liquidity
50%
Performance
80%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-3.92%
Return on sales
-962.02%
Return on invested capital
0%
Total debt ratio
78.68%
Debt ratio change over timeo
-2.06%
Current Ratio
12.9%
Quick Ratio
0%
Cash Position Ratio
2.86%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
3.84%
Return on sales
-27.36%
Return on invested capital
0%
Total debt ratio
100.85%
Debt ratio change over timeo
0%
Current Ratio
8.55%
Quick Ratio
0%
Cash Position Ratio
3.13%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
18.36%
Return on sales
61.8%
Return on invested capital
0%
Total debt ratio
89.79%
Debt ratio change over time
0%
Current Ratio
9.07%
Quick Ratio
0%
Cash Position Ratio
6.17%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-88.59%
Return on sales
7252.84%
Return on invested capital
0%
Total debt ratio
-205.8%
Debt ratio change over time
-2.06%
Current Ratio
-59.19%
Quick Ratio
0%
Cash Position Ratio
-19.9%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ANAB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -3.92% | 4.74% | 3.19% | 1.73% |
| Return on sales | -962.02% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 78.68% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -2.06% | -20.57% | -85.61% | 17.33% |
| Dept financing | 21% | 21% | 16% | 50% |
| Current Ratio | 8.55% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 3.13% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 29% | 31% | 22% |
| Short-term ratios | ANAB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 3.84% | 6.06% | 4.18% | 1.7% |
| Return on sales | -27.36% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 66% | 50% | 34% | 23% |
| Total debt ratio | 100.85% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 20% | 15% | 25% |
| Current Ratio | 8.55% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 3.13% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 30% | 25% | 17% |